123 related articles for article (PubMed ID: 32490596)
1. New antiglaucomatous agent for the treatment of open angle glaucoma: Polymeric inserts for drug release and in vitro and in vivo study.
Cesar ALA; Navarro LC; Castilho RO; Goulart GAC; Foureaux G; Ferreira AJ; Cronemberger S; Gomes Faraco AA
J Biomed Mater Res A; 2021 Mar; 109(3):336-345. PubMed ID: 32490596
[TBL] [Abstract][Full Text] [Related]
2. Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats.
Foureaux G; Franca JR; Nogueira JC; Fulgêncio Gde O; Ribeiro TG; Castilho RO; Yoshida MI; Fuscaldi LL; Fernandes SO; Cardoso VN; Cronemberger S; Faraco AA; Ferreira AJ
PLoS One; 2015; 10(7):e0133149. PubMed ID: 26204514
[TBL] [Abstract][Full Text] [Related]
3. Chitosan/hydroxyethyl cellulose inserts for sustained-release of dorzolamide for glaucoma treatment: In vitro and in vivo evaluation.
Franca JR; Foureaux G; Fuscaldi LL; Ribeiro TG; Castilho RO; Yoshida MI; Cardoso VN; Fernandes SOA; Cronemberger S; Nogueira JC; Ferreira AJ; Faraco AAG
Int J Pharm; 2019 Oct; 570():118662. PubMed ID: 31491481
[TBL] [Abstract][Full Text] [Related]
4. Bimatoprost-loaded ocular inserts as sustained release drug delivery systems for glaucoma treatment: in vitro and in vivo evaluation.
Franca JR; Foureaux G; Fuscaldi LL; Ribeiro TG; Rodrigues LB; Bravo R; Castilho RO; Yoshida MI; Cardoso VN; Fernandes SO; Cronemberger S; Ferreira AJ; Faraco AA
PLoS One; 2014; 9(4):e95461. PubMed ID: 24788066
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: preparation and in vitro/in vivo evaluation.
Aburahma MH; Mahmoud AA
AAPS PharmSciTech; 2011 Dec; 12(4):1335-47. PubMed ID: 21979886
[TBL] [Abstract][Full Text] [Related]
6. Combination of self-assembling system and N,O-carboxymethyl chitosan improves ocular residence of anti-glaucoma drug.
Kailasam V; Kumara BN; Prasad KS; Nirmal J
Eur J Pharm Biopharm; 2024 Apr; 197():114208. PubMed ID: 38336235
[TBL] [Abstract][Full Text] [Related]
7. The role of the lecithin addition in the properties and cytotoxic activity of chitosan and chondroitin sulfate nanoparticles containing curcumin.
Jardim KV; Siqueira JLN; Báo SN; Sousa MH; Parize AL
Carbohydr Polym; 2020 Jan; 227():115351. PubMed ID: 31590861
[TBL] [Abstract][Full Text] [Related]
8. Topical Bimatoprost Insert for Primary Open-Angle Glaucoma and Ocular Hypertension Treatment - A Phase II Controlled Study.
Rubião F; Araújo ACF; Sancio JB; Nogueira BS; Franca JR; Nogueira JC; Ferreira AJ; Faraco AAG; Foureaux G; Cronemberger S
Curr Drug Deliv; 2021; 18(7):1022-1026. PubMed ID: 33388018
[TBL] [Abstract][Full Text] [Related]
9. Sustained release ocular inserts of brimonidine tartrate for better treatment in open-angle glaucoma.
Bhagav P; Trivedi V; Shah D; Chandran S
Drug Deliv Transl Res; 2011 Apr; 1(2):161-74. PubMed ID: 25788114
[TBL] [Abstract][Full Text] [Related]
10. Formulation and evaluation of sustained release ocular inserts of betaxolol hydrochloride using arabinoxylan from Plantago ovata.
Sajid Chughtai FR; Zaman M; Khan AH; Amjad MW; Aman W; Khan SM; Ghafoor Raja MA; Nadeem Alvi M; Afridi M; Hanif M
Pak J Pharm Sci; 2021 May; 34(3(Supplementary)):1069-1074. PubMed ID: 34602434
[TBL] [Abstract][Full Text] [Related]
11. Long acting betaxolol ocular inserts based on polymer composite.
Gevariya HB; Patel JK
Curr Drug Deliv; 2013 Aug; 10(4):384-93. PubMed ID: 23909665
[TBL] [Abstract][Full Text] [Related]
12. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
[TBL] [Abstract][Full Text] [Related]
13. Phenylboronic acid-tethered chondroitin sulfate-based mucoadhesive nanostructured lipid carriers for the treatment of dry eye syndrome.
Tan G; Li J; Song Y; Yu Y; Liu D; Pan W
Acta Biomater; 2019 Nov; 99():350-362. PubMed ID: 31449929
[TBL] [Abstract][Full Text] [Related]
14. Influence of charge on FITC-BSA-loaded chondroitin sulfate-chitosan nanoparticles upon cell uptake in human Caco-2 cell monolayers.
Hu CS; Chiang CH; Hong PD; Yeh MK
Int J Nanomedicine; 2012; 7():4861-72. PubMed ID: 23028215
[TBL] [Abstract][Full Text] [Related]
15. Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments.
Hernández M; Urcola JH; Vecino E
Exp Eye Res; 2008 May; 86(5):798-806. PubMed ID: 18394603
[TBL] [Abstract][Full Text] [Related]
16. Reduction of intraocular pressure using timolol orally dissolving strips in the treatment of induced primary open-angle glaucoma in rabbits.
El-Feky YA; Mostafa DA; Al-Sawahli MM; El-Telbany RFA; Zakaria S; Fayez AM; Ahmed KA; Alolayan EM; El-Telbany DFA
J Pharm Pharmacol; 2020 May; 72(5):682-698. PubMed ID: 32170884
[TBL] [Abstract][Full Text] [Related]
17. [Aiming for zero blindness].
Nakazawa T
Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
[TBL] [Abstract][Full Text] [Related]
18. Dual drug delivery from vitamin E loaded contact lenses for glaucoma therapy.
Hsu KH; Carbia BE; Plummer C; Chauhan A
Eur J Pharm Biopharm; 2015 Aug; 94():312-21. PubMed ID: 26071799
[TBL] [Abstract][Full Text] [Related]
19. Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery system.
Ribeiro TG; Chávez-Fumagalli MA; Valadares DG; França JR; Rodrigues LB; Duarte MC; Lage PS; Andrade PH; Lage DP; Arruda LV; Abánades DR; Costa LE; Martins VT; Tavares CA; Castilho RO; Coelho EA; Faraco AA
Int J Nanomedicine; 2014; 9():877-90. PubMed ID: 24627630
[TBL] [Abstract][Full Text] [Related]
20. Curcumin In Situ Gelling Polymeric Insert with Enhanced Ocular Performance.
Abdelkader H; Wertheim D; Pierscionek B; Alany RG
Pharmaceutics; 2020 Nov; 12(12):. PubMed ID: 33260494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
